Market closed
Walgreens/$WBA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Walgreens
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Ticker
$WBA
Sector
Trading on
Industry
Consumer Staples Distribution & Retail
Headquarters
Employees
252,500
Walgreens Metrics
BasicAdvanced
$9.4B
-
-$6.69
0.64
$0.75
9.20%
Price and volume
Market cap
$9.4B
Beta
0.64
52-week high
$18.83
52-week low
$8.08
Average daily volume
16M
Dividend rate
$0.75
Financial strength
Current ratio
0.611
Quick ratio
0.266
Long term debt to equity
375.262
Total debt to equity
428.707
Interest coverage (TTM)
-1.21%
Management effectiveness
Return on assets (TTM)
-0.59%
Return on equity (TTM)
-66.21%
Valuation
Price to revenue (TTM)
0.062
Price to book
1.32
Price to tangible book (TTM)
-0.61
Price to free cash flow (TTM)
16.442
Dividend yield (TTM)
6.90%
Forward dividend yield
9.20%
Growth
Revenue change (TTM)
5.08%
Earnings per share change (TTM)
-4.39%
3-year revenue growth (CAGR)
3.78%
3-year earnings per share growth (CAGR)
-2.66%
3-year dividend per share growth (CAGR)
-26.64%
What the Analysts think about Walgreens
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Walgreens stock.
Walgreens Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Walgreens Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Walgreens News
AllArticlesVideos
Walgreens to pay up to $350M for filling illegal opioid prescriptions, Justice Department says
Fox Business·23 hours ago
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says
Reuters·2 days ago
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025
Business Wire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Walgreens stock?
Walgreens (WBA) has a market cap of $9.4B as of April 23, 2025.
What is the P/E ratio for Walgreens stock?
The price to earnings (P/E) ratio for Walgreens (WBA) stock is 0 as of April 23, 2025.
Does Walgreens stock pay dividends?
Yes, the Walgreens (WBA) stock pays dividends to shareholders. As of April 23, 2025, the dividend rate is $0.75 and the yield is 9.2%. Walgreens has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Walgreens dividend payment date?
The next Walgreens (WBA) dividend payment date is unconfirmed.
What is the beta indicator for Walgreens?
Walgreens (WBA) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.